Paul Tudor Jones Biomea Fusion, Inc. Transaction History
Tudor Investment Corp Et Al
- $25.1 Billion
- Q4 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 17,612 shares of BMEA stock, worth $40,507. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,612
Previous 17,838
1.27%
Holding current value
$40,507
Previous $180,000
62.22%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BMEA
# of Institutions
126Shares Held
17.5MCall Options Held
1.8MPut Options Held
1.08M-
Cormorant Asset Management, LP Boston, MA3.57MShares$8.21 Million1.09% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$5.39 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY1.45MShares$3.34 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.4MShares$3.22 Million0.0% of portfolio
-
Aisling Capital Management LP New York, NY799KShares$1.84 Million1.14% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $67.4M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...